IDO1 and neoplasm: In cold tumors, IDO1 immunostaining of tumor cells varied between 0 and 90% (mean: 31%, SD: 34%), and altered immunosuppressed neoplasms displayed IDO1 labeling in 1–80% of tumor cells (mean: 26%, SD: 30%).